It has been long experimentally demonstrated that human alpha-fetoprotein (HAFP) has an ability to bind immobilized estrogens with the most e±ciency for synthetic estrogen analog À À À diethylstilbestrol (DES). However, the question remains why the human AFP (HAFP), unlike rodent AFP, cannot bind free estrogens. Moreover, despite the fact that AFP was¯rst discovered more than 50 years ago and is presently recognized as a \golden standard" among oncobiomarkers, its three-dimensional (3D) structure has not been experimentally solved yet. In this work using MODELLER program, we generated 3D model of HAFP on the basis of homology with human serum albumin (HSA) and Vitamin DÀbinding protein (VTDB) with subsequent molecular docking of DES to the model structure and molecular dynamics (MD) simulation study of the complex obtained. The model constructed has U-shaped structure in which a cavity may be distinguished. In this cavity the putative estrogen-binding site is localized. Validation by RMSD calculation and with the use of PROCHECK program showed good quality of the model and stability of extended region of four alpha-helical structures that contains putative hormone-binding residues. Data extracted from MD simulation trajectory allow proposing two types of interactions between amino acid residues of HAFP and DES molecule: (1) hydrogen bonding with involvement of residues S445, R452, and E551; (2) hydrophobic interactions with participation of L138, M448, and M548 residues. A suggestion is made that immobilization of the hormone using a long spacer provides delivery of the estrogen molecule to the binding site and, thereby, facilitates interaction between HAFP and the hormone.
Introduction
Alpha-fetoprotein (AFP) is the major mammalian tumorÀassociated fetal protein that is normally present in the blood of adults only in small quantities (up to 10À20 ng/ml).
1,2 AFP has been recognized as a growth regulator during embryonic development and tumor progression. 3 It has been shown that AFP in dose-dependent manner stimulates growth of estrogen-resistant tumors and inhibits growth of estrogen-sensitive ones.
Chemically, AFP is a glycoprotein with molecular weight (MW) of about 68À73 kDa and carbohydrate content of 3%À5%. Primary structure of full-length human AFP (HAFP) molecule is represented by 609 amino acid (aa) residues from which a signal peptide of 18 aa residues is removed during processing to yield the mature protein of 591 aa residues. 4, 5 AFP belongs to the family of proteins À À À products of albuminoid genes, which are located in tandem arrangement in chromosome 4 (region 4q11Àq13). 6 This family includes (Table 1) , besides AFP itself, also serum albumin (SA), Vitamin DÀbinding protein (VTDB) and alpha-albumin (afamin). Proteins of this family are evolutionary closely related and originate from the common ancestor. 7 They demonstrate considerable similarity of their primary structures with characteristic distribution of disulphide bonds.
AFP and SA show the highest degree of identity (up to 40%) and similarity (taking into account conservative substitutions of aa residues) up to 60% amongst the family members. Proteins of this family also demonstrate similar -helical secondary structure (for example, up to 65%À67% -helices in AFP and about 50% in SA). It has been shown using electron microscopy, image processing and circular dichroism that AFP and SA have U-shaped spatial organization and consist of three homologous domains (I, II and III). 8 Each domain is composed of two subdomains that are designated as IA, IB, IIA, IIB, IIIA and IIIB and possess common structural motifs. It has been also shown that the principal regions of ligand-binding in human serum albumin (HSA) are located in hydrophobic cavities in subdomains IIA and IIIA, which exhibit similar chemistry.
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As for 3D structure of proteins of this family, numerous crystal structures of human SA and VTDB free of ligands or complexed with variety of low molecular weight hydrophobic ligands have been obtained. 12À16 To date (December 2011), 86 crystal structures of HSA itself and in complexes with fatty acids, drugs, bilirubin, thyroxine and heme at resolutions between 1.90À3.20 Å are present in the Protein Data Bank (PDB). 17 Also six crystal structures of VTDB uncomplexed or in complexes with vitamin D and its metabolites and also with skeletal actin are determined and exist in PDB.
However, the precise 3D structure of HAFP has not been experimentally obtained yet. This is because of di±culties in crystallization of this protein that impede study of 3D structure of HAFP by experimental procedures such as X-ray di®raction and nuclear magnetic resonance (NMR) spectroscopy. Identity degree (40%) between primary structures of AFP and SA is quite enough to make it possible comparative modeling of three-dimensional structure of AFP on the basis of homology with SA. 18 Homology-based modeling is a computer-based approach that employs the fact that spatial structures of homologous proteins are evolutionary more conserved than their amino acid sequences provided by identity degree higher than 30%. 19 This method allows constructing an atomic resolution structural model of a \target" protein from its amino acid sequence that is aligned with that of homologous \template" protein of known, experimentally obtained, 3D structure. It can provide models useful for generating hypotheses about functions of proteins and the role of conserved aa residues in binding of low-molecular-weight ligands.
It has been long demonstrated that AFP from di®erent sources binds and, seemingly, transports various hydrophobic ligands including estrogens, fatty acids, bilirubin, some drugs and dyes. 20, 21 Studying of estrogen-binding ability of AFP is of crucial importance since this ability provides regulation of free active forms of hormones in conditions in vivo. In this way AFP is supposed to protect embryonic tissues from circulating maternal estrogens. However, binding of natural free estrogens has been evidently demonstrated only for mouse and rat alpha-fetoproteins (MAFP and RAFP, respectively). For HAFP, an ability to bind immobilized estrogens with the highest e±ciency for synthetic analog of estrogens À À À diethylstilbestrol (DES) À À À has been shown. 22 In the latter work, HAFP was isolated from embryonic tissues by extraction with butanol that leads to delipidation of HAFP molecule to make its estrogen-binding sites free from hormones and fatty acids. Also, a suggestion has been made that immobilization is required for proper orientation of the hormone molecule that is necessary for its binding to HAFP molecule.
In order to identify amino acid residues required for estrogen binding, 17 mutant human AFPs were produced by site-directed mutagenesis. 23 In these mutant HAFPs some amino acid residues were substituted with those in RAFP at corresponding positions. Substitutions of amino acid residues in the domain III, namely, A455V, A456S, T457I, L469R, L470S, A476L and I480Y resulted in obtaining of HAFP molecules that showed signi¯cant ability to bind free estrogens. The conclusion was made that aa residues V455, S456, I457, R469, S470, L476, Y480 should be at the corresponding positions of HAFP to convert it into the form that able to bind estrogens.
Using native and recombinant chimeric rat-human proteins it has been identi¯ed that estrogen-binding region of rodent AFP encompasses amino acid residues from 423 to 506 located in the domain III. 24 In this region the peptide segment composed of 15 aa residues with sequence ELIDLTGKMVSIAST (aa 448À462 in rat AFP and aa 442À456 in mouse AFP) has been proposed to be a primary high-a±nity (Kd about 10 À8 M) estrogen-binding site of rodent AFP (Table 2) . In human AFP, the peptide motif composed of aa residues 446À460 with sequence ELMAITRKMAA-TAAT, has been suggested to be the primary high-a±nity estrogen-binding site on the basis of amino acid matching with rodent AFP. 25 Besides, synthetic peptide derived from HAFP, namely AADIIIGHLCIRHEM (aa residues 476À490), has been experimentally demonstrated to bind 17-estradiol (E2) with moderate a±nity (Kd about 10 À5 M). 26 The latter sequence was proposed to be a secondary, low-a±nity estrogen-binding site. So, it may be concluded that estrogen binding by HAFP should take place with involvement of amino acid residues which are included in the region 446À490 in the full-length molecule.
Nevertheless, the precise molecular mechanisms of estrogen binding to HAFP and the role of de¯nite aa residues in this process have not been elucidated yet. In this work we generated the 3D structure of HAFP on the basis of homology with HSA and VTDB followed by docking of synthetic estrogen analog diethylstilbestrol. Subsequent molecular dynamics (MD) simulation study was performed to optimize the model and to elucidate amino acid residues that, putatively, participate in the proteinÀhormone interaction.
Materials and Methods

Template selection and sequence alignment
Homology-based modeling is an e®ective method for predicting 3D structure of a protein, provided by experimentally obtained 3D structure of homologous protein.
The latter can serve as a template molecule for model generation. Correct template selection in homology-based modeling is one of the most important factors that provide high quality of the model constructed. 27 Here candidate templates for human AFP were searched from PDB database. To identify the best template the following criteria were used: close relationship to AFP, similar functions, relatively high degree of sequence identity, experimentally observed secondary structure similarity, and also high resolution of experimentally obtained 3D structure of the template molecule. Using these approaches two 3D structures as templates were chosen from PDB data base À À À those of human serum albumin (accession number in PDB 1E78) and VTDB (accession number in PDB 1KW2). Crystal structures for both proteins were determined by X-ray di®raction method at high resolutions: 2.6 Å for HSA and 2.15 Å for VTDB. Note: (*) indicates identity, (:) À À À conservative substitutions.
Modeling of 3D Structure of Human Alpha-Fetoprotein
Amino acid sequences of the template molecules were aligned to the sequence of human AFP. The sequences of HSA (P02768), human VTDB (P02774) and HAFP (P02771) were retrieved in FASTA format from NCBI (National Center for Biotechnology Information) UniProtKB/Swiss-Prot database (http://www.uniprot. org/). 28 Sequence alignment was performed using the program for global multiple alignment ClustalW, version 2.0. 29 
Model generation, optimization and validation
The 3D model of human alpha-fetoprotein was generated using the MODELLER 9v6 program package for comparative modeling and protein structure prediction. 30 This is the most commonly used software that utilizes spatial-restraint method to construct 3D structure by calculating positions of all heavy atoms in a target protein from data experimentally obtained for template protein molecule. Restraints are applied to the main protein internal coordinates À À À protein backbone distances and dihedral angles. They serve as the basis for global optimization procedure by conjugate energy minimization. 31, 32 To perform optimization and relaxation of the model constructed and to assess its stability MD simulation at the trajectory length of 5 ns was carried out. Assessment of the model accuracy was performed using the following two methods. The¯rst one was comparing two protein structures À À À those of initial model constructed and of the model structure during 5 ns MD simulation. This method uses the root-mean-square deviation (RMSD) metric to measure the mean distances between the corresponding atoms in the two structures after they have been superimposed. 33, 34 In this work, calculation of RMSD values were performed for four extended alpha-helices located in the cavity revealed in the model structure. This region contains hypothetical estrogen-binding site and was of our special interest to estimate possibility for docking of the estrogen molecule to HAFP.
The second method used for validation of our 3D model was PROCHECK, version 3.5, program that veri¯ed the conformational and stereochemical parameters of amino acid residues of a protein. These parameters are: combinations of dihedral angles ' and values, peptide bond planarity, main chain and side chain parameters, main chain covalent bond lengths and angles, residue-by-residue stereochemical properties such as absolute deviation of torsion angles and CÀchirality. 35, 36 Also, it allowed receiving information about secondary structure elements and estimated solvent accessible areas. Judgment about how \normal" or \unusual" is a given stereochemical property was done by measuring G-factor. A low (or negative) G-factor indicates that the property corresponds to a low-probability conformation. So, PROCHECK program allows judging about a model quality by revealing poor and unusual geometry along a protein sequence.
Construction of DES molecule
Synthetically obtained analog of estrogens DES was used as a ligand for docking. Construction of the ligand molecule was performed with the use of HyperChem (version 8.0) molecular modeling software. 37 Modeling of the hormone molecule ( Fig. 1 ) was carried out in the full-atomic approximation in Amber potential forcē eld. 38, 39 The force¯eld parameters were extended with experimental data obtained by quantum chemistry calculations performed with the use of GAMESS software package. 40 E®ective charges on atoms were calculated using Mulliken method. 41 The hormone molecule constructed was placed in the periodic box of 20 Â 20 Â 20 Å in size with explicit water environment. Geometry optimization of the ligand structure was performed by energy minimization with the use of restricted HartreeÀFock method and the standard basis set 6-31GF. 42 
Docking of DES to human AFP model constructed
Using of 3D structure constructed by homology-based modeling approach for molecular docking is possible because functional regions of a protein, especially its binding sites, tend to be more highly conserved and thus more accurately modeled. 43 Program package AutoDock (version 4.0) 44 was used to perform automated docking of the estrogen molecule to binding site of HAFP model obtained. In this study, semi-°exible docking was performed where the protein and ligand structures were kept as rigid, but amino acid residues that are hypothesized to participate in estrogen-binding after preliminary docking were kept°exible. These were the following¯ve aa residues: Q428, M448, R452, V543 and T547.
The protocol for this semi-°exible protein-estrogen docking consisted of 10 independent runs per ligand, using an initial population of 100 randomly placed individuals, with 2:5 Â 10 6 energy evaluations, a maximum number of 27,000 iterations, a mutation rate of 0.02, and a crossover rate of 0.80.
Step sizes were 0.2 Å for translations, 5:0 for quaternions and 5:0 for torsions. For docking simulation, cluster tolerance was set at 0.5 Å and external grid energy was kept at 1000 kcal, with maximum initial energy 0.0 kcal. The probability to perform a local search on an individual in the population was 0.06, using a maximum of 300 iterations per local search. The best conformers were selected on the basis of Lamarckian Genetic Algorithm (LGA). After docking, the best 10 solutions were clustered into groups with RMSD lower than 1.0 Å. The clusters were ranked by the lowest energy representative of each cluster.
Molecular dynamics simulation protocol
The complexes obtained were subjected to molecular dynamics simulation at trajectory length of 5 ns. Two MD simulations were carried out: one for optimization of HAFP model generated, the second for the docked HAFP-DES complex structure. The latter was performed to investigate conformational mobility of the protein backbone and to take information about interaction between amino acid residues of the binding site and the hormone molecule.
MD simulations both in case of relaxation of 3D model of HAFP itself and in case of the HAFP-DES complex were performed using the same parameter sets (protocols). GROMACS software package (version 3.3.1) was utilized. 45 MD simulation was performed in periodic box with sizes 70 Â 100 Â 100 Å and with the use of explicit water model. Cuto® distances for electrostatic and van der Waals interactions were given to be equal to 2 nm. LINKS algorithm for¯xation of covalent bonds was used. Stochastic dynamics as an algorithm for integration was used to maintain constant temperature in OPLS-AA force¯eld. Time constant for temperature coupling was 0.2 ps. Integration step length was 2 fs. Sodium (Na þ ) and chlorine (Cl À ) ions were added to the system to neutralize charges.
Results
Overall architecture of the structural model
Sequence alignment showed 40% identity and 60% overall similarity between HAFP and HSA [ Fig. 2(a) ]. It is known that a model tends to be reliable, with only minor errors in side chain packing and rotameric state, if identity degree between the template and target proteins is above 50%. Great structural di®erences arise if identity degree decreases to 20%. 18 So, identity degree between our template and target sequences (40%) is quite enough to perform homology-based modeling with subsequent docking of the hormone molecule, especially if take into account that identity degree is highest (48%) in the domain III, where the putative estrogen-binding site of HAFP is located. Usage of VTDB as an additional template increases reliability of the model constructed in spite of only 21% identity between HAFP and VTDB [ Fig. 2(b) ]. Low degree of identity between the two latter proteins is due to the fact that VTDB is truncated at its C-terminus and contains only 80 aa residues in its domain III as a result of molecular evolution. 46 Full-length molecules of HAFP and HSA contain 609 aa residues whereas of VTDB À À À only 474 aa residues are present.
Sequence alignment between HAFP and HSA [ Fig. 2(a) ] with indication of secondary structure elements shows that there is low amount of°exible loop regions in The model generated was stored as PDB output¯le and then visualized and analyzed using UCSF Chimera package. 47 Visualization of the model showed that it has U-shaped structure with a cavity formed by domains I and III. So, the structure of our model is in accordance with experimental data obtained by combining dark-¯eld 
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electron microscopy with laser-assisted optical system that allow producing relative mass map of a molecule. 8 This map showed asymmetrical structural features of HAFP molecule, notably, three-mass dense regions at both extremities and at the vertex of the molecule. Each of these regions corresponds to domains I, II and III of HAFP. Figure 3 shows visualization of the overall HAFP 3D model in two types of representation. The¯rst one is ribbon [ Fig. 3(a) ] representation with indication of three-domain structure and the second one is surface [ Fig. 3(b) ] representation where the cavity is well visualized. Walls in the cavity are predominantly formed by four -helices that contain, mainly, hydrophilic amino acid residues with hydrophobic areas that involve aa residues L138, V141, V145, L447, M448, A449, I450, M454, A455, A456, A458, A459. Hypothetical estrogen-binding site is located in this cavity and involves aa residues of the following alpha-helical regions: 144À158, 442À460, 466À490, 542À559 [ Fig. 3(a) ].
Validation of the model structure
Calculation of RMSD was performed for the model structure during relaxation by 5 ns equilibrium MD simulation in respect with the initial model structure. RMSD values (Fig. 4) for extended alpha-helical regions that form walls of the cavity that contain hypothetical estrogen-binding site of HAFP and encompass aa residues 144À158, 442À460, 466À490 and 542À599 are stabilized after 500 ps MD simulation and vary between 0.30 and 0.40 nm indicating metastability of the binding site conformation. Variations in RMSD value were due to internal dynamics of the protein and low frequency°uctuations and motions of four alpha helices in relation to each other in explicit water environment. PROCHECK (version 3.5) program was further used for the analysis of the model quality. To estimate conformational properties of all aa residues of the 3D model, the program draws Ramachandran map that contains values of combinations of the protein backbone dihedral angles ' and for its each residue. Analysis of the Ramachandran map for amino acid residues of the obtained HAFP 3D model showed high-quality parameters for conformations of all non-glycine and non-proline residues (540 in total). The plot statistics was as follows. The main chain conformations for 498 (92.2%) of these amino acid residues were within the most favored regions, 41 (7.6%) residues were in the additional allowed regions, 0% À À À in the generously allowed regions and only 1 (0.2%) residue (A39) was located in disallowed region (Fig. 5) . The number of glycine and proline residues were 26 and 21, respectively.
Individual residue geometrical properties may also be used to assess the quality of the model because they may vary along a protein sequence. PROCHECK program draws various graphs and diagrams that give information about regions with consistently poor or unusual geometry. These diagrams drawn for our model showed that absolute deviations from mean values of torsion angles 1, ! and (CÀchirality) are low enough (Fig. 6) . The amount of residues that deviate by more than 2.0 standard deviations from ideal, i.e. with unusual geometry (R121, F202, Q291, K304, K384, C500, F533, T564 and E566) was small and consisted only 1.53% from the total amount of amino acid residues. Secondary structure elements correspond to -helices and random coils, with no -structures. The amount of -helices is in accordance with experimental data and constitutes about 69% from the modeled polypeptide chain length. Experimentally obtained data show that amount of -helical regions comprise up to 67% from fulllength molecule. Our model has a little higher amount of -helices then in experiments because of absence of N-terminal part of the polypeptide chain that seems to be predominantly unstructured in the native molecule.
Estimation of water accessibility areas showed that four -helices that encompass aa residues (142À158, 442À460, 466À490 and 542À559) of putative estrogen-binding site are mostly buried indicating enrichment in hydrophobic aa residues. The program estimated also G-factor values for combinations of 'À , 1À2, 3À4, and ! torsion angles along with the main chain bonds and angles. Analysis of all these diagrams also showed that the model constructed is reliable and useful for further characterization of the protein.
Docking DES molecule to HAFP model
Low RMSD values calculated for hypothetical estrogen-binding site indicate reasonable good quality of this part of the model and allow performing of docking of the ligand to HAFP model constructed. The AutoDock (version 4.0) software package was used to perform partly°exible (induced¯t) molecular docking with the aim to search global energy minimum of interaction between the HAFP model and DES. In this way, the docking studies allow exploring the real binding environment, where the ligand molecule interacts with the target protein. This is especially valuable in case if a structure of ligandbinding site is not experimentally obtained.
In this study, the following aa residues were given as°exible: Q428, M448, R452, V543 and T547. It was shown that DES molecule is docked to a part of an extended -helical structure on the bottom of the cavity in HAFP model, including cluster of hydrophobic aa residues (Fig. 7) . Aromatic benzene rings of DES, seemingly, interact with hydrophobic aa residues M448, A449 and V543. The interaction is also provided by hydrogen bonding: oxygen atoms in the side chains of residues S445 and E551 are seemed to form hydrogen bonds with hydroxyl groups of DES. The corresponding distances are: 1.95 Å between OG atom of residue S445 and H-atom of the¯rst hydroxyl (HO1) of DES, and 1.69 Å between OE1 atom of residue E551 and the H-atom of the second hydroxyl group (HO2) of the hormone.
Interestingly, all interacting aa residues belong to subdomains IIIA and IIIB of HAFP. The thermodynamic characteristics of DES binding to HAFP was estimated using value of free energy change (ÁG) that was equal to À4.24 kcal/mol for the best docked complex. Fig. 7 . Docking of DES to estrogen-binding site of the 3D model of HAFP. Amino acid residues that are localized close to the hormone are shown. DES is docked to alpha-helices on the bottom of the cavity. Free energy change (ÁG) was estimated as À4.24 kcal/mol for the best complex.
Putative estrogen-binding residues revealed by MD simulation
Molecular dynamics simulation of the HAFP-DES complex was performed based on the docked complex structure to obtain a dynamical picture of conformational changes along with detailed and precise information about interaction between HAFP and the hormone molecule. The trajectory from the 5 ns MD simulation was used to extract data about types of interaction and aa residues that participate in them. Visualization of the complex (Fig. 8) shows that the hormone molecule changes its position during MD simulation and interacts not only with aa residues of the main -helices in subdomains IIIA and IIIB (S445, M448, R452, M548 and E551), but also aa residues located in subdomain IB (L138).
To calculate distances for hydrophobic interactions, we took centers of mass of side chains of residues L138, M448, I450 and M548 and aromatic rings of the hormone. This increases interaction distances because the van der Waals radii of all atoms of side chains of the residues should be taken into account. Here, the smallest distances are observed between aromatic ring A of DES and centers of masses of the residues L138 and M448 side chains: they vary, mainly, from 0.50 to 0.80 nm [Figs. 9(a) and 9(b)].
For hydrogen bonding, distances were calculated between separate atoms. The smallest distances were observed between S445, E551 and second hydroxyl group of DES and also between R452 and¯rst hydroxyl group of DES. Figure 9 depicts distances between two pairs of oxygen atoms: between OE1 atom of glutamic acid E551 and OH2 atom of the second hydroxyl group of DES [ Fig. 9(c) ] and between OG atom of serine S445 and OH2 atom of DES [ Fig. 9(d) ]. Small distances observed after 2 ns of MD simulation indicate possibility of interaction between these atoms through formation of hydrogen bonds. A conclusion may be made that interactions between the hormone and the estrogen-binding site is, seemingly, provided by two sets of amino acid residues: (1) hydrophobic side chains of amino acid residues in HAFP (L138, M448 and M548) that interact with aromatic rings of DES; and (2) hydrogen bonding with participation of OH-groups of the hormone and polar atoms in HAFP amino acid side chains (S445, R452 and E551).
Discussion
Human AFP domains I and II include 192 amino acids each (residues 19À210 and 211À402, respectively); domain III consists of 199 residues (residues 403À601). The 
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highest identity degree between primary structures of HAFP and HSA is found in the domain III (48%), whereas the lowest identity is found in the subdomain IA (16%). 48 Since the method of homology modeling relies on the assembly of conserved structural elements and also because variable regions are typically located in the loops where the majority of the sequence di®erences are localized, it was necessary to estimate the secondary structure elements. Pairwise alignment with indication of secondary structure elements in both the template molecules shows (Fig. 2) that amount of°exible loop regions is not high (about 23% in HSA and 22% in VTDB). Pairwise comparison of primary structures of AFP and albumin from various animal species revealed that identity degree between these proteins reduced from human to dog, horse, mouse, and rat. So, a divergence vector from a common ancestor increases in this order and demonstrates the highest conservation of aa sequences for the pair of HAFPÀHSA. All these observations along with the fact that 3D structures of proteins are more conserved then their primary structures allow us to construct 3D model of HAFP on the basis of homology with HSA.
Validation of the entire model of HAFP using PROCHECK v3.5 program showed its good quality and reliability. Indeed, the Ramachandran plot drawn for the model structure indicates that the amount of amino acid residues with conformations in the most favored region is more than 90% (92.2%) and the total amount of residues in the most favored and allowed regions is 99.8%. An assessment of residue-by-residue stereo-chemical parameters showed that amino acid residues from 446 to 490 that compose the proposed estrogen-binding site have no unusual stereo-chemical properties.
The model constructed in this work has a U-shaped structure (Fig. 3) and this shape corresponds to that obtained experimentally by methods of electron microscopy, image processing and circular dichroism. 8 The overall architecture of the model corresponds to three-domain structure demonstrated by these methods. The secondary structure elements of the model also correspond to those obtained in experiments that demonstrated existence of -helices and random coils with no -structures. Also, the amount of -helical regions is close to the experimental data. So, the model structure is in good agreement with the data obtained experimentally, and this proves accuracy of the model generated in this work.
The model obtained explains that the U-shaped structure of HAFP provides formation of the cavity between domains I and III. It is thought that this shape of the entire molecule along with existence of the cavity is not casual. This is of special importance since the putative estrogen-binding sites (both high and low a±nity) are located in this cavity. Earlier, with the use of a±nity chromatography method, we showed that both free and immobilized diethylstilbestrol has the highest e±ciency of binding to HAFP in comparison to natural estrogens. 22 As for naturally occurring estrogens (17-estradiol and estriol), it has been shown that only immobilized hormones are able to bind to HAFP, suggesting the importance of spatial orientation of the hormone molecules to the estrogen-binding site in in vivo conditions. Probably, it is because of the planarity of structures of naturally occurring estrogens. However, binding to HAFP of both natural estrogens and their synthetic analog (DES) depends on the length of spacer and the mode of immobilization. It may be suggested that the immobilization of the hormone using a long spacer provides access of estrogen molecule to the binding site and, thereby, facilitates interaction between HAFP and estrogens.
Also, it may be proposed that the conformational changes that take place in HAFP molecule are of crucial importance during estrogen binding. It has been demonstrated that high concentrations of estrogens (in ratio of molar concentrations of AFP to E2 as 1:1280) cause conformational changes in the AFP molecule. 26 It has also been shown that domains I and III of HAFP have a rigid tightly packed tertiary structure, whereas domain II has the conformation that corresponds to the molten globule form (MGF). The C-terminal part of domain II is considered as a \hinge region," responsible for conformational°exibility of all domains. 8 This promotes interaction of ligand molecules, including estrogens with their binding sites in HAFP molecule.
The calculation of RMSD values was performed for four extended -helices located in the cavity that contains a hypothetical estrogen-binding site and was of special interest to us. This method showed metastability and reasonable good quality of this part of the model. This allows docking of DES molecule to the model structure with subsequent MD simulation study that revealed amino acid residues involved in the hormone-binding. On the basis of data obtained it is suggested that interaction between DES and HAFP takes place through: (1) formation of hydrogen bonds with participation of OH-groups of the hormone and polar atoms of S445, R452, and E551 residues; and (2) van der Waals interactions with involvement of hydrophobic side chains of L138 and M448 residues and aromatic benzene rings (and ethyl groups) of DES. It may be concluded that most aa residues that bind DES are located in the subdomains IIIA and IIIB of HAFP. Importantly, these data are in agreement with experimentally obtained data, which demonstrated that estrogen-binding amino acid residues should be located in the domain III of HAFP.
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The model constructed in this work should also be validated in experiments. This can be done, for example, by rational design of new ligands and their subsequent testing in vitro or in vivo.
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